1. Generics Bulletin
  2. >>Business
  3. >>Deals

Hikma And Richter Partner On Cariprazine In MENA Markets

 
• By Akriti Seth

Hikma and Richter enter into an agreement to supply and commercialise cariprazine, an antipsychotic treatment for patients suffering from schizophrenia, in 14 MENA markets.

Middle_East_Map
Hikma and Richter target MENA markets for their antipsychotic treatment for schizophrenic patients • Source: Shutterstock

Hikma Pharmaceuticals and Gedeon Richter have announced an exclusive licensing agreement to commercialize cariprazine, an antipsychotic treatment for patients suffering from schizophrenia. The partnership targets certain Middle East and North African (MENA) markets.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business